California Public Employees Retirement System grew its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 9.9% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 365,778 shares of the company's stock after acquiring an additional 32,807 shares during the period. California Public Employees Retirement System owned about 0.42% of HealthEquity worth $35,096,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also recently modified their holdings of the company. Smartleaf Asset Management LLC grew its position in shares of HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after buying an additional 98 shares in the last quarter. Louisiana State Employees Retirement System increased its holdings in shares of HealthEquity by 0.4% in the 4th quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company's stock valued at $2,322,000 after acquiring an additional 100 shares during the period. Oregon Public Employees Retirement Fund increased its stake in HealthEquity by 0.6% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company's stock valued at $1,706,000 after purchasing an additional 100 shares during the period. State of Michigan Retirement System increased its position in HealthEquity by 0.5% in the 4th quarter. State of Michigan Retirement System now owns 20,722 shares of the company's stock valued at $1,988,000 after acquiring an additional 100 shares during the period. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in shares of HealthEquity by 0.6% during the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 19,286 shares of the company's stock worth $1,850,000 after purchasing an additional 106 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company's stock.
HealthEquity Stock Up 2.0 %
HealthEquity stock traded up $1.56 during midday trading on Monday, hitting $80.36. 1,593,191 shares of the stock were exchanged, compared to its average volume of 744,564. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59. The company has a 50 day moving average price of $101.18 and a two-hundred day moving average price of $96.48. The firm has a market cap of $6.95 billion, a P/E ratio of 73.72, a P/E/G ratio of 1.60 and a beta of 0.49.
Insiders Place Their Bets
In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the transaction, the director now owns 78,219 shares of the company's stock, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 2.20% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
HQY has been the subject of several recent analyst reports. KeyCorp reduced their price target on HealthEquity from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Monday, March 24th. Raymond James upgraded shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and lowered their price target for the company from $120.00 to $115.00 in a research report on Tuesday, March 25th. JMP Securities upped their target price on shares of HealthEquity from $105.00 to $107.00 and gave the company a "market outperform" rating in a report on Tuesday, December 10th. Wells Fargo & Company increased their price target on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research note on Wednesday, February 26th. Finally, The Goldman Sachs Group cut their price objective on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a report on Thursday, March 27th. One research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, HealthEquity currently has a consensus rating of "Buy" and a consensus price target of $112.58.
View Our Latest Research Report on HealthEquity
HealthEquity Profile
(
Free Report)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Further Reading

Before you consider HealthEquity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.
While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.